A

180 Life Sciences Corp

ATNF

2.11000
USD
0.05
(2.43%)
Market Closed
Volume
2,924
EPS
0
Div Yield
0
P/E
-0
Market Cap
3,850,988
Related Instruments
AZN
2.040
(2.58%)
81.200 USD
B
BNTX
-5.530
(-6.42%)
80.570 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRNA
-25.020
(-20.99%)
94.160 USD
N
NVAX
-0.250
(-1.95%)
12.560 USD
PFE
0.115
(0.38%)
30.650 USD
V
VXRT
-0.01170
(-1.74%)
0.65890 USD
News

Title: 180 Life Sciences Corp

Sector: Healthcare
Industry: Biotechnology
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate,combination therapy.